pembrolizumab TMB-High Malignant Solid Tumor Metastatic, +1 more state No standard/acceptable treatment, +1 more context pembrolizumab immunotherapy
pembrolizumab TMB-High Thyroid Gland Papillary Carcinoma Advanced, +2 more states pembrolizumab immunotherapy
pembrolizumab TMB-High Malignant Testicular Germ Cell Tumor Metastatic Third line pembrolizumab immunotherapy
pembrolizumab TMB-High Malignant Nasopharyngeal Neoplasm Metastatic, +2 more states Subsequent line pembrolizumab immunotherapy
pembrolizumab TMB-High Soft Tissue Sarcoma Metastatic, +1 more state No standard/acceptable treatment, +1 more context pembrolizumab immunotherapy
pembrolizumab TMB-High Ampulla of Vater Adenocarcinoma Metastatic First line, +1 more context pembrolizumab immunotherapy
pembrolizumab TMB-High Squamous Cell Carcinoma of the Penis Metastatic, +1 more state Subsequent line pembrolizumab immunotherapy
pembrolizumab TMB-High Prostate Adenocarcinoma Castration-resistant, +1 more state Subsequent line pembrolizumab immunotherapy
pembrolizumab TMB-High Pancreatic Adenocarcinoma Locally advanced, +2 more states Subsequent line pembrolizumab immunotherapy
pembrolizumab TMB-High Fallopian Tube Carcinoma, +2 more conditions Recurrent pembrolizumab immunotherapy